In the Framingham Study 2325 men and 2866 women 30 to 62 years old at entry were followed biennially over 22 years for the development of chronic atrial fibrillation in relation to antecedent cardiovascular disease and risk factors. During surveillance, atrial fibrillation developed in 49 men and 49 women. The incidence rose sharply with age but did not differ significantly between the sexes. Overall, there was a 2.0 per cent chance that the disorder would develop in two decades. Atrial fibrillation usually followed the development of overt cardiovascular disease. Only 18 men and 12 women (31 per cent) had chronic atrial fibrillation in the absence of cardiovascular disease. Cardiac failure and rheumatic heart disease were the most powerful predictive precursors, with relative risks in excess of sixfold. Hypertensive cardiovascular disease was the most common antecedent disease, largely because of its frequency in the general population. Among the risk factors for cardiovascular disease, diabetes and electrocardiographic evidence of left ventricular hypertrophy were related to the occurrence of atrial fibrillation. The development of chronic atrial fibrillation was associated with a doubling of overall mortality and of mortality from cardiovascular disease.
This article has been cited by other articles:
Sridhar, A., Nishijima, Y., Terentyev, D., Khan, M., Terentyeva, R., Hamlin, R. L., Nakayama, T., Gyorke, S., Cardounel, A. J., Carnes, C. A.
(2009). Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc Res
84: 227-236
[Abstract][Full Text]
Anter, E., Callans, D. J.
(2009). Pharmacological and Electrical Conversion of Atrial Fibrillation to Sinus Rhythm Is Worth the Effort. Circulation
120: 1436-1443
[Full Text]
Maggioni, A. P., Fabbri, G., Lucci, D., Marchioli, R., Franzosi, M. G., Latini, R., Nicolosi, G. L., Porcu, M., Cosmi, F., Stefanelli, S., Tognoni, G., Tavazzi, L., on behalf of the GISSI-HF Investigators,
(2009). Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial. Eur Heart J
30: 2327-2336
[Abstract][Full Text]
Nichols, G. A., Reinier, K., Chugh, S. S.
(2009). Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation. Diabetes Care
32: 1851-1856
[Abstract][Full Text]
Forleo, G. B., Tondo, C.
(2009). Atrial fibrillation: cure or treat?. Ther Adv Cardiovasc Dis
3: 187-196
[Abstract]
Stein, K. M., Mittal, S., Gilliam, F. R., Gilligan, D. M., Zhong, Q., Kraus, S. M., Meyer, T. E.
(2009). Predictors of early mortality in implantable cardioverter-defibrillator recipients. Europace
11: 734-740
[Abstract][Full Text]
Anter, E., Jessup, M., Callans, D. J.
(2009). Atrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic. Circulation
119: 2516-2525
[Full Text]
Du, X., Ninomiya, T., de Galan, B., Abadir, E., Chalmers, J., Pillai, A., Woodward, M., Cooper, M., Harrap, S., Hamet, P., Poulter, N., Lip, G. Y.H., Patel, A., on behalf of the ADVANCE Collaborative Group,
(2009). Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J
30: 1128-1135
[Abstract][Full Text]
The GISSI-AF Investigators,
(2009). Valsartan for Prevention of Recurrent Atrial Fibrillation. NEJM
360: 1606-1617
[Abstract][Full Text]
Beyer, E., Lee, R., Lam, B.-K.
(2009). Point: Minimally invasive bipolar radiofrequency ablation of lone atrial fibrillation: early multicenter results.. J. Thorac. Cardiovasc. Surg.
137: 521-526
[Abstract][Full Text]
Nucifora, G., Schuijf, J. D., Tops, L. F., van Werkhoven, J. M., Kajander, S., Jukema, J. W., Schreur, J. H.M., Heijenbrok, M. W., Trines, S. A., Gaemperli, O., Turta, O., Kaufmann, P. A., Knuuti, J., Schalij, M. J., Bax, J. J.
(2009). Prevalence of Coronary Artery Disease Assessed by Multislice Computed Tomography Coronary Angiography in Patients With Paroxysmal or Persistent Atrial Fibrillation. Circ Cardiovasc Imaging
2: 100-106
[Abstract][Full Text]
Kato, K., Fujimaki, T., Yoshida, T., Oguri, M., Yajima, K., Hibino, T., Murohara, T.
(2009). Impact of matrix metalloproteinase-2 levels on long-term outcome following pharmacological or electrical cardioversion in patients with atrial fibrillation. Europace
11: 332-337
[Abstract][Full Text]
Magnani, J. W., Williamson, M. A., Ellinor, P. T., Monahan, K. M., Benjamin, E. J.
(2009). P Wave Indices: Current Status and Future Directions in Epidemiology, Clinical, and Research Applications. Circ Arrhythm Electrophysiol
2: 72-79
[Full Text]
Ricci, R. P., Morichelli, L., Santini, M.
(2009). Remote control of implanted devices through Home MonitoringTM technology improves detection and clinical management of atrial fibrillation. Europace
11: 54-61
[Abstract][Full Text]
Conen, D., Tedrow, U. B., Cook, N. R., Moorthy, M. V., Buring, J. E., Albert, C. M.
(2008). Alcohol Consumption and Risk of Incident Atrial Fibrillation in Women. JAMA
300: 2489-2496
[Abstract][Full Text]
Lundberg, C., Albage, A., Carnlof, C., Kenneback, G.
(2008). Long-Term Health-Related Quality of Life After Maze Surgery for Atrial Fibrillation. Ann. Thorac. Surg.
86: 1878-1882
[Abstract][Full Text]
Zhang, Q., Yip, G. W.-K., Yu, C.-M.
(2008). Approaching regional left atrial function by tissue Doppler velocity and strain imaging. Europace
10: iii62-iii69
[Abstract][Full Text]
Schoonderwoerd, B. A., Smit, M. D., Pen, L., Van Gelder, I. C.
(2008). New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'. Europace
10: 668-673
[Abstract][Full Text]
Lutomsky, B. A., Rostock, T., Koops, A., Steven, D., Mullerleile, K., Servatius, H., Drewitz, I., Ueberschar, D., Plagemann, T., Ventura, R., Meinertz, T., Willems, S.
(2008). Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace
10: 593-599
[Abstract][Full Text]
Molina, L., Mont, L., Marrugat, J., Berruezo, A., Brugada, J., Bruguera, J., Rebato, C., Elosua, R.
(2008). Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace
10: 618-623
[Abstract][Full Text]
Thomas, L., Hoy, M., Byth, K., Schiller, N. B.
(2008). The left atrial function index: a rhythm independent marker of atrial function. Eur J Echocardiogr
9: 356-362
[Abstract][Full Text]
Noheria, A., Kumar, A., Wylie, J. V. Jr, Josephson, M. E.
(2008). Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation: A Systematic Review. Arch Intern Med
168: 581-586
[Abstract][Full Text]
Nguyen, J. T., Benditt, D. G.
(2008). Atrial Fibrillation Susceptibility in Metabolic Syndrome: Simply the Sum of Its Parts?. Circulation
117: 1249-1251
[Full Text]
Watanabe, H., Tanabe, N., Watanabe, T., Darbar, D., Roden, D. M., Sasaki, S., Aizawa, Y.
(2008). Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study. Circulation
117: 1255-1260
[Abstract][Full Text]
Cosio, F. G., Aliot, E., Botto, G. L., Heidbuchel, H., Geller, C. J., Kirchhof, P., De Haro, J.-C., Frank, R., Villacastin, J. P., Vijgen, J., Crijns, H.
(2008). Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode. Europace
10: 21-27
[Abstract][Full Text]
Boyd, A. C., Schiller, N. B., Ross, D. L., Thomas, L.
(2008). Segmental atrial contraction in patients restored to sinus rhythm after cardioversion for chronic atrial fibrillation: a colour Doppler tissue imaging study. Eur J Echocardiogr
9: 12-17
[Abstract][Full Text]
Laurent, G., Moe, G., Hu, X., Holub, B., Leong-Poi, H., Trogadis, J., Connelly, K., Courtman, D., Strauss, B. H., Dorian, P.
(2008). Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model. Cardiovasc Res
77: 89-97
[Abstract][Full Text]
Occhetta, E., Bortnik, M., Dell'Era, G., Zardo, F., Dametto, E., Sassone, B., Gabrieli, L., Marino, P.
(2007). Evaluation of pacemaker dependence in patients on ablate and pace therapy for atrial fibrillation. Europace
9: 1119-1123
[Abstract][Full Text]
Burstein, B., Qi, X.-Y., Yeh, Y.-H., Calderone, A., Nattel, S.
(2007). Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: A novel consideration in atrial remodeling. Cardiovasc Res
76: 442-452
[Abstract][Full Text]
Tardif, J.-C., Talajic, M.
(2007). Perindopril and prevention of atrial fibrillation. Eur Heart J Suppl
9: E25-E29
[Abstract][Full Text]
Varounis, C., Dagres, N., Maounis, T., Panagiotakos, D., Cokkinos, D. V.
(2007). Atrial premature complexes and heart rate have prognostic significance in 1-month atrial fibrillation recurrence after electrical cardioversion. Europace
9: 633-637
[Abstract][Full Text]
Gradaus, R., Seidl, K., Korte, T., Himmrich, E., Wieneke, H., Schuchert, A., Bauer, W., Gerss, J., Wollmann, C. G., Borggrefe, M., Bocker, D.
(2007). Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study. Europace
9: 534-539
[Abstract][Full Text]
Lian, J., Mussig, D., Lang, V.
(2007). Ventricular rate smoothing for atrial fibrillation: a quantitative comparison study. Europace
9: 506-513
[Abstract][Full Text]
Nergardh, A. K, Rosenqvist, M., Nordlander, R., Frick, M.
(2007). Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study. Eur Heart J
28: 1351-1357
[Abstract][Full Text]
Wierup, P., Liden, H., Johansson, B., Nilsson, M., Edvardsson, N., W.-O. Berglin, E.
(2007). Health Care Consumption Due to Atrial Fibrillation is Markedly Reduced by Maze III Surgery. Ann. Thorac. Surg.
83: 1713-1716
[Abstract][Full Text]
Lian, J., Mussig, D., Lang, V.
(2007). On the role of ventricular conduction time in rate stabilization for atrial fibrillation. Europace
9: 289-293
[Abstract][Full Text]
Choudhury, A., Chung, I., Blann, A. D., Lip, G. Y. H.
(2007). Elevated Platelet Microparticle Levels in Nonvalvular Atrial Fibrillation: Relationship to P-Selectin and Antithrombotic Therapy. Chest
131: 809-815
[Abstract][Full Text]
Park, H., Hildreth, A., Thomson, R., O'Connell, J.
(2007). Non-valvular atrial fibrillation and cognitive decline: a longitudinal cohort study. Age Ageing
36: 157-163
[Abstract][Full Text]
Bertaglia, E., Stabile, G., Senatore, G., Colella, A., Del Greco, M., Goessinger, H., Lamberti, F., Lowe, M., Mantovan, R., Peters, N., Pratola, C., Raatikainen, P., Turco, P., Verlato, R.
(2007). A clinical and health-economic evaluation of pulmonary vein encircling ablation compared with antiarrhythmic drug treatment in patients with persistent atrial fibrillation (Catheter Ablation for the Cure of Atrial Fibrillation-2 study). Europace
9: 182-185
[Abstract][Full Text]
Heeringa, J., van der Kuip, D. A. M., Hofman, A., Kors, J. A., van Rooij, F. J. A., Lip, G. Y. H., Witteman, J. C. M.
(2007). Subclinical Atherosclerosis and Risk of Atrial Fibrillation: The Rotterdam Study. Arch Intern Med
167: 382-387
[Abstract][Full Text]
Ozdemir, O., Soylu, M., Demir, A. D., Topaloglu, S., Alyan, O., Geyik, B., Kutuk, E.
(2007). P-Wave Durations in Patients Experiencing Atrial Fibrillation During Exercise Testing. ANGIOLOGY
58: 97-101
[Abstract]
Finch, S. J., van Zyl, L. T.
(2006). Cardioversion of Persistent Atrial Arrhythmia After Treatment With Venlafaxine in Successful Management of Major Depression and Posttraumatic Stress Disorder. Psychosomatics
47: 533-536
[Abstract][Full Text]
Ngaage, D. L., Schaff, H. V., Barnes, S. A., Sundt, T. M. III, Mullany, C. J., Dearani, J. A., Daly, R. C., Orszulak, T. A.
(2006). Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: is there an argument for concomitant arrhythmia surgery?. Ann. Thorac. Surg.
82: 1392-1399
[Abstract][Full Text]
Writing Committee Members, , Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L.
(2006). ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace
8: 651-745
[Full Text]
Nergardh, A, Frick, M
(2006). Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation. Heart
92: 1244-1247
[Abstract][Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S.
(2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society . J Am Coll Cardiol
48: e149-e246
[Full Text]
Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA TASK FORCE MEMBERS, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC COMMITTEE FOR PRACTICE GUIDELINES, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L.
(2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation
114: e257-e354
[Full Text]
Holmqvist, F., Stridh, M., Waktare, J. E.P., Roijer, A., Sornmo, L., Platonov, P. G., Meurling, C. J.
(2006). Atrial fibrillation signal organization predicts sinus rhythm maintenance in patients undergoing cardioversion of atrial fibrillation. Europace
8: 559-565
[Abstract][Full Text]
Yamanaka, K., Fujita, M., Doi, K., Tsuneyoshi, H., Yamazato, A., Ueno, K., Zen, E., Komeda, M.
(2006). Multislice Computed Tomography Accurately Quantifies Left Atrial Size and Function After the MAZE Procedure. Circulation
114: I-5-I-9
[Abstract][Full Text]
Heeringa, J., van der Kuip, D. A.M., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H.Ch., Stijnen, T., Lip, G. Y.H., Witteman, J. C.M.
(2006). Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J
27: 949-953
[Abstract][Full Text]
Pruitt, J. C., Lazzara, R. R., Dworkin, G. H., Badhwar, V., Kuma, C., Ebra, G.
(2006). Totally Endoscopic Ablation of Lone Atrial Fibrillation: Initial Clinical Experience. Ann. Thorac. Surg.
81: 1325-1331
[Abstract][Full Text]
Knaut, M., Tugtekin, S. M., Spitzer, S. G., Jung, F., Matschke, K.
(2006). Intraoperative endocardial microwave ablation for treatment of permanent atrial fibrillation during coronary artery bypass surgery: 1-year follow-up.. Europace
8: 16-20
[Abstract][Full Text]
Doukas, G., Samani, N. J., Alexiou, C., Oc, M., Chin, D. T., Stafford, P. G., Ng, L. L., Spyt, T. J.
(2005). Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial Fibrillation: A Randomized Controlled Trial. JAMA
294: 2323-2329
[Abstract][Full Text]
Milliez, P., DeAngelis, N., Rucker-Martin, C., Leenhardt, A., Vicaut, E., Robidel, E., Beaufils, P., Delcayre, C., Hatem, S. N.
(2005). Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. Eur Heart J
26: 2193-2199
[Abstract][Full Text]
Dixon, B. J., Bracha, Y., Loecke, S. W., Guerrero, M. A., Taylor, R. D., Asinger, R. W.
(2005). Principal Atrial Fibrillation Discharges by the New ACC/AHA/ESC Classification. Arch Intern Med
165: 1877-1881
[Abstract][Full Text]
Kabbani, S. S, Murad, G., Jamil, H., Sabbagh, A., Hamzeh, K.
(2005). Ablation of Atrial Fibrillation Using Microwave Energy - Early Experience. Asian Cardiovasc. Thorac. Ann.
13: 247-250
[Abstract][Full Text]
Pelliccia, A., Maron, B. J., Di Paolo, F. M., Biffi, A., Quattrini, F. M., Pisicchio, C., Roselli, A., Caselli, S., Culasso, F.
(2005). Prevalence and Clinical Significance of Left Atrial Remodeling in Competitive Athletes. J Am Coll Cardiol
46: 690-696
[Abstract][Full Text]
Demircan, C, Cikriklar, H I, Engindeniz, Z, Cebicci, H, Atar, N, Guler, V, Unlu, E O, Ozdemir, B
(2005). Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation. Emerg. Med. J.
22: 411-414
[Abstract][Full Text]
Katira, R, Chauhan, A, More, R S
(2005). Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation. Postgrad. Med. J.
81: 370-375
[Abstract][Full Text]
Kimura, K, Minematsu, K, Yamaguchi, T, for the Japan Multicenter Stroke Investigators' Co,
(2005). Atrial fibrillation as a predictive factor for severe stroke and early death in 15 831 patients with acute ischaemic stroke. J. Neurol. Neurosurg. Psychiatry
76: 679-683
[Abstract][Full Text]
Gersh, B. J., Tsang, T. S.M., Barnes, M. E., Seward, J. B.
(2005). The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factors. Eur Heart J Suppl
7: C5-C11
[Abstract][Full Text]
Lam, B-K., Boodhwani, M., Veinot, J. P., Hendry, P. J., Mesana, T. G.
(2005). Surgical treatment of atrial fibrillation with diathermy: an in vitro study. Eur. J. Cardiothorac. Surg.
27: 456-461
[Abstract][Full Text]
Kabukcu, M., Arslantas, E., Ates, I., Demircioglu, F., Ersel, F.
(2005). Clinical, Echocardiographic, and Hemodynamic Characteristics of Rheumatic Mitral Valve Stenosis and Atrial Fibrillation. ANGIOLOGY
56: 159-163
[Abstract]
Iqbal, M B., Taneja, A. K, Lip, G. Y H, Flather, M.
(2005). Recent developments in atrial fibrillation. BMJ
330: 238-243
[Full Text]
Golovchiner, G., Mazur, A., Kogan, A., Strasberg, B., Shapira, Y., Fridman, M., Kuzniec, J., Vidne, B. A., Raanani, E.
(2005). Atrial Flutter After Surgical Radiofrequency Ablation of the Left Atrium for Atrial Fibrillation. Ann. Thorac. Surg.
79: 108-112
[Abstract][Full Text]
Bella, P. D., Riva, S., Fassini, G., Casella, M., Carbucicchio, C., Trevisi, N., Berti, M., Giraldi, F., Maccabelli, G.
(2005). Long-term follow-up after radiofrequency catheter ablation of atrial fibrillation: Role of the acute procedure outcome and of the clinical presentation. Europace
7: 95-103
[Abstract][Full Text]
Mangin, L., Vinet, A., Pagé, P., Glass, L.
(2005). Effects of antiarrhythmic drug therapy on atrioventricular nodal function during atrial fibrillation in humans. Europace
7: S71-S82
[Abstract][Full Text]
Lin, C.-C., Lin, J.-L., Lin, C.-S., Tsai, M.-C., Su, M.-J., Lai, L.-P., Huang, S. K. S.
(2004). Activation of the Calcineurin-Nuclear Factor of Activated T-Cell Signal Transduction Pathway in Atrial Fibrillation. Chest
126: 1926-1932
[Abstract][Full Text]
Kang, Y., Daly, B. J., Kim, J.-S.
(2004). Uncertainty and Its Antecedents in Patients With A trial Fibrillation. West J Nurs Res
26: 770-783
[Abstract]
Yamada, H., Mowrey, K. A., Popovic, Z. B., Kowalewski, W. J., Martin, D. O., Thomas, J. D., Wallick, D. W.
(2004). Coupled pacing improves cardiac efficiency during acute atrial fibrillation with or without cardiac dysfunction. Am. J. Physiol. Heart Circ. Physiol.
287: H2016-H2022
[Abstract][Full Text]
Knaut, M., Tugtekin, S. M., Jung, F., Matschke, K.
(2004). Microwave ablation for the surgical treatment of permanent atrial fibrillation--a single centre experience. Eur. J. Cardiothorac. Surg.
26: 742-746
[Abstract][Full Text]
Hagens, V. E., Vermeulen, K. M., TenVergert, E. M., Van Veldhuisen, D. J., Bosker, H. A., Kamp, O., Kingma, J. H., Tijssen, J. G.P., Crijns, H. J.G.M., Van Gelder, I. C., for the RAte Control versus Electrical cardioversi,
(2004). Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation -- results from the RAte Control versus Electrical cardioversion (RACE) study. Eur Heart J
25: 1542-1549
[Abstract][Full Text]
Lloyd-Jones, D. M., Wang, T. J., Leip, E. P., Larson, M. G., Levy, D., Vasan, R. S., D'Agostino, R. B., Massaro, J. M., Beiser, A., Wolf, P. A., Benjamin, E. J.
(2004). Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study. Circulation
110: 1042-1046
[Abstract][Full Text]
Hanna, I. R., Kolm, P., Martin, R., Reisman, M., Gray, W., Block, P. C.
(2004). Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO): Six-month echocardiographic follow-up. J Am Coll Cardiol
43: 1868-1872
[Abstract][Full Text]
Lindholm, C-J A, Fredholm, O, Moller, S-J, Edvardsson, N, Kronvall, T, Pettersson, T, Firsovaite, V, Roijer, A, Meurling, C J, Platonov, P G, Olsson, S B
(2004). Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil. Heart
90: 534-538
[Abstract][Full Text]
Vora, A., Karnad, D., Goyal, V., Naik, A., Gupta, A., Lokhandwala, Y., Kulkarni, H., Singh, B. N.
(2004). Control of Heart Rate Versus Rhythm in Rheumatic Atrial Fibrillation: A Randomized Study. J CARDIOVASC PHARMACOL THER
9: 65-73
[Abstract]
Szalay, Z. A., Civelek, A., Dill, T., Klovekorn, W. P., Kilb, I., Bauer, E. P.
(2004). Long-term follow-up after the mini-maze procedure. Ann. Thorac. Surg.
77: 1277-1281
[Abstract][Full Text]
Romano, M. A., Bach, D. S., Pagani, F. D., Prager, R. L., Deeb, G. M., Bolling, S. F.
(2004). Atrial reduction plasty Cox maze procedure: extended indications for atrial fibrillation surgery. Ann. Thorac. Surg.
77: 1282-1287
[Abstract][Full Text]
Chen, M. S., Marrouche, N. F., Khaykin, Y., Gillinov, A. M., Wazni, O., Martin, D. O., Rossillo, A., Verma, A., Cummings, J., Erciyes, D., Saad, E., Bhargava, M., Bash, D., Schweikert, R., Burkhardt, D., Williams-Andrews, M., Perez-Lugones, A., Abdul-Karim, A., Saliba, W., Natale, A.
(2004). Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol
43: 1004-1009
[Abstract][Full Text]
Previous
